Basic Information
| RNALocate ID: | RLID:11003522 |
| RNA Symbol: | hsa-miR-769-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-769-5p |
| RNA ID: | miRBase:MIMAT0003886 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002543 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003521 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003523 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11003524 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11003525 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000175 | Exosome | B lymphoblastoid cells|Endothelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000560 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-769-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-69329 |
| MNDR | hsa-miR-769-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-69330 |
| MNDR | hsa-miR-769-5p | Lymphoma | MNDR-E-MI-69331 |
| MNDR | hsa-miR-769-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-69332 |
| MNDR | hsa-miR-769-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-69333 |
| MNDR | hsa-miR-769-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-69334 |
| MNDR | hsa-miR-769-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-69335 |
| MNDR | hsa-miR-769-5p | Breast cancer luminal | MNDR-E-MI-69336 |
| MNDR | hsa-miR-769-5p | Prostate cancer | MNDR-E-MI-69337 |
| MNDR | hsa-miR-769-5p | Gastric cancer | MNDR-E-MI-69338 |
| MNDR | hsa-miR-769-5p | Alzheimer disease | MNDR-E-MI-69339 |
| MNDR | hsa-miR-769-5p | Intracranial aneurysm | MNDR-E-MI-69340 |
| MNDR | hsa-miR-769-5p | Head and neck cancer | MNDR-E-MI-69341 |
| MNDR | hsa-miR-769-5p | Leukemia | MNDR-E-MI-69342 |
| MNDR | hsa-miR-769-5p | Cardiovascular disease | MNDR-E-MI-69343 |
| MNDR | hsa-miR-769-5p | Lung cancer | MNDR-E-MI-69344 |
| MNDR | hsa-miR-769-5p | Parkinson disease | MNDR-E-MI-69345 |
| MNDR | hsa-miR-769-5p | Breast cancer | MNDR-E-MI-69346 |
| MNDR | hsa-miR-769-5p | Pituitary neoplasms | MNDR-E-MI-69347 |
| MNDR | hsa-miR-769-5p | Pancreatic cancer | MNDR-E-MI-69348 |
| MNDR | hsa-miR-769-5p | Rectum adenocarcinoma | MNDR-E-MI-69349 |
| MNDR | hsa-miR-769-5p | Colon cancer | MNDR-E-MI-69350 |
| MNDR | hsa-miR-769-5p | Colon adenocarcinoma | MNDR-E-MI-69351 |
| MNDR | hsa-miR-769-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-69352 |
| MNDR | hsa-miR-769-5p | Ovarian cancer | MNDR-E-MI-69353 |
| MNDR | hsa-miR-769-5p | Acromegaly | MNDR-E-MI-69354 |
| MNDR | hsa-miR-769-5p | Carcinoma ductal breast | MNDR-E-MI-69355 |
| MNDR | hsa-miR-769-5p | Malignant glioma | MNDR-E-MI-69356 |
| MNDR | hsa-miR-769-5p | Osteosarcoma | MNDR-E-MI-69357 |
| MNDR | hsa-miR-769-5p | Pituitary adenoma | MNDR-E-MI-69358 |
| MNDR | hsa-miR-769-5p | Lung squamous cell carcinoma | MNDR-E-MI-69359 |
| MNDR | hsa-miR-769-5p | Non-small cell lung cancer | MNDR-E-MI-69360 |
| MNDR | hsa-miR-769-5p | Lung adenocarcinoma | MNDR-E-MI-69361 |
| MNDR | hsa-miR-769-5p | Adrenocortical cancer | MNDR-E-MI-69362 |
| MNDR | hsa-miR-769-5p | Thyroid carcinoma | MNDR-E-MI-69363 |
| MNDR | hsa-miR-769-5p | Ovarian carcinoma | MNDR-E-MI-69364 |
| MNDR | hsa-miR-769-5p | Pancreatic adenocarcinoma | MNDR-E-MI-69365 |
| MNDR | hsa-miR-769-5p | Carcinoma renal cell | MNDR-E-MI-69366 |
| MNDR | hsa-miR-769-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-69367 |
| MNDR | hsa-miR-769-5p | Renal clear cell carcinoma | MNDR-E-MI-69368 |
| MNDR | hsa-miR-769-5p | Cholangiocarcinoma | MNDR-E-MI-69369 |
| MNDR | hsa-miR-769-5p | Liver cirrhosis | MNDR-E-MI-69370 |
| MNDR | hsa-miR-769-5p | Lung small cell carcinoma | MNDR-E-MI-69371 |
| MNDR | hsa-miR-769-5p | Synovial sarcoma | MNDR-E-MI-69372 |
| MNDR | hsa-miR-769-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-69373 |
| MNDR | hsa-miR-769-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-69374 |
| MNDR | hsa-miR-769-5p | Adenoma | MNDR-E-MI-69375 |
| MNDR | hsa-miR-769-5p | Breast invasive carcinoma | MNDR-E-MI-69376 |
| MNDR | hsa-miR-769-5p | Hepatocellular carcinoma | MNDR-E-MI-69377 |
| MNDR | hsa-miR-769-5p | Rheumatoid arthritis | MNDR-E-MI-69378 |
| MNDR | hsa-miR-769-5p | Hodgkin lymphoma | MNDR-E-MI-69379 |
| MNDR | hsa-miR-769-5p | Skin cutaneous melanoma | MNDR-E-MI-69380 |
| MNDR | hsa-miR-769-5p | Skin melanoma | MNDR-E-MI-69381 |
| MNDR | hsa-miR-769-5p | Acute myeloid leukemia | MNDR-E-MI-69382 |
| MNDR | hsa-miR-769-5p | Colorectal cancer | MNDR-E-MI-69383 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | GSK3B | Homo sapiens | RR00644438 |
TOP